Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04891978 · ClinicalTrials.gov registry record · NA
US PRECISION Implementation Study
A NA study, sponsored by AstraZeneca.
- Completed
- Registry status
- NA
- Development phase
- 857
- Enrollment target
NCT04891978 is a NA study that has completed, run by AstraZeneca. The registered enrollment target is 857 participants.
The verdict
NCT04891978, a NA study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- NA
- Development phase
- 857 participants
- Enrollment target
Study Summary
The primary objective of this community program intervention study is to assess the process and potential benefits of integrating the AIRQ®, Asthma Checklist, and educational resources (PRECISION program) into clinical practice using either in-person or telehealth visits. The secondary objectives are to assess asthma patients' clinic visit experiences when the AIRQ, the Asthma Checklist, and educational resources (PRECISION program) are utilized as part of a telehealth or in-person visit with their HCP, and to explore change in AIRQ scores from the initial visit to follow-up visit(s) (when available).
Interventions
- BEHAVIORAL AIRQ
- BEHAVIORAL Asthma Checklist
- BEHAVIORAL PRECISION Program (Educational Resources)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 857 participants |
| Start Date | 2021-04-20 |
| Est. Completion | 2023-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04891978
The ClinicalTrials.gov registry entry for NCT04891978 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 857 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which AIRQ is the first listed.
NCT04891978 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04891978 about?
NCT04891978 is a clinical study titled "US PRECISION Implementation Study". The primary objective of this community program intervention study is to assess the process and potential benefits of integrating the AIRQ®, Asthma Checklist, and educational resources (PRECISION program) into clinical practice using either in-person or telehealth visits. The secondary objectives a...
What is the current status of trial NCT04891978?
This trial is currently completed. It is a NA study. The enrollment target is 857 participants. The study started on 2021-04-20. Estimated completion is 2023-04-30.
What interventions are being tested in trial NCT04891978?
The interventions under investigation include: AIRQ (BEHAVIORAL), Asthma Checklist (BEHAVIORAL), PRECISION Program (Educational Resources) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04891978?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.